Reuters: IPOX® Associate Lukas Muehlbauer Comments on Oura’s Confidential U.S. IPO Filing

Reuters reported that Oura Health Oy, Finnish maker of the smart wearable Oura Ring, has confidentially filed to go public in the United States as IPO momentum returns. The article noted that the U.S. IPO market has rebounded after a brief March slowdown, with renewed investor interest in new listings amid broader market uncertainty.

IPOX® Associate Lukas Muehlbauer was quoted in the article discussing investor appetite for Oura and the company’s positioning within the health-tech sector. Reuters highlighted Oura’s reported valuation of about $11 billion, its more than 5.5 million rings sold worldwide, and its expansion across more than 4,600 retail locations globally.

Muehlbauer noted that Oura may benefit from renewed demand for health-tech listings and from its recurring revenue profile and growth channels:

“Investor appetite for Oura should be decent on the back of recent health-tech listings, suggesting that buyers are returning to companies with repeat revenue and paths to profit.”

“It now has partnerships across health, sport, retail and enterprise channels. That gives the company more ways to grow and makes the brand harder to copy.”

Read the full article by Pritam Biswas and Arasu Kannagi Basil on Reuters: Oura ring maker files confidentially to go public in US as IPO momentum returns

Previous
Previous

CNBC: IPOX® Founder Josef Schuster Comments on SpaceX IPO Access and Investor Caution

Next
Next

Reuters: IPOX® Associate Lukas Muehlbauer Comments on SpaceX IPO and Broader Listing Trends